Preventing Cardiac Complications of COVID-19 Disease with Early Acute Coronary Syndrome Therapy (C19-ACS)
This randomised controlled trial aims to determine whether acute coronary syndromes are occurring during COVID-19 disease and not being adequately diagnosed and treated.
|Imperial PI||Professor Prapa Kanagaratnam
Professor Darrel Francis
|Trial Sponsor||Imperial College London|
|Study status||In recruitment|
Find out more about this study here.
App to inform & enrol patients Study Documents Explainer video